These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 34107350)

  • 1. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
    Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
    Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
    Harris MA; Shen X; Cox SR; Gibson J; Adams MJ; Clarke TK; Deary IJ; Lawrie SM; McIntosh AM; Whalley HC
    Psychol Med; 2020 Jul; 50(10):1653-1662. PubMed ID: 31317844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
    Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
    J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key subphenotypes of bipolar disorder are differentially associated with polygenic liabilities for bipolar disorder, schizophrenia, and major depressive disorder.
    Song J; Jonsson L; Lu Y; Bergen SE; Karlsson R; Smedler E; Gordon-Smith K; Jones I; Jones L; Craddock N; Sullivan PF; Lichtenstein P; Di Florio A; Landén M
    Mol Psychiatry; 2024 Jul; 29(7):1941-1950. PubMed ID: 38355785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes.
    Su MH; Shih YH; Lin YF; Chen PC; Chen CY; Hsiao PC; Pan YJ; Liu YL; Tsai SJ; Kuo PH; Wu CS; Huang YT; Wang SH
    Diabetologia; 2022 May; 65(5):800-810. PubMed ID: 35195735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohorts.
    Whalley HC; Adams MJ; Hall LS; Clarke TK; Fernandez-Pujals AM; Gibson J; Wigmore E; Hafferty J; Hagenaars SP; Davies G; Campbell A; Hayward C; Lawrie SM; Porteous DJ; Deary IJ; McIntosh AM
    Transl Psychiatry; 2016 Nov; 6(11):e938. PubMed ID: 27801894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank.
    Leppert B; Millard LAC; Riglin L; Davey Smith G; Thapar A; Tilling K; Walton E; Stergiakouli E
    PLoS Genet; 2020 May; 16(5):e1008185. PubMed ID: 32392212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder.
    Li Z; Li D; Chen X
    J Affect Disord; 2022 Jul; 309():242-251. PubMed ID: 35487438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.
    David FS; Stein F; Andlauer TFM; Streit F; Witt SH; Herms S; Hoffmann P; Heilmann-Heimbach S; Opel N; Repple J; Jansen A; Nenadić I; Papiol S; Heilbronner U; Kalman JL; Schaupp SK; Senner F; Schulte EC; Falkai PG; Schulze TG; Dannlowski U; Kircher T; Rietschel M; Nöthen MM; Krug A; Forstner AJ
    Schizophr Res; 2023 Feb; 252():161-171. PubMed ID: 36652833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism.
    Ward J; Le NQ; Suryakant S; Brody JA; Amouyel P; Boland A; Bown R; Cullen B; Debette S; Deleuze JF; Emmerich J; Graham N; Germain M; Anderson JJ; Pell JP; Lyall DM; Lyall LM; Smith DJ; Wiggins KL; Soria JM; Souto JC; Morange PE; Smith NL; Trégouët DA; Sabater-Lleal M; Strawbridge RJ
    Blood Adv; 2023 Sep; 7(18):5341-5350. PubMed ID: 37399490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.
    Liebers DT; Pirooznia M; Seiffudin F; Musliner KL; Zandi PP; Goes FS
    Schizophr Bull; 2016 Jul; 42(4):984-91. PubMed ID: 26873889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of healthy lifestyle factors and genetic liability with bipolar disorder: Findings from the UK Biobank.
    Li G; He Q; Sun M; Ma Z; Zhao H; Wang Y; Feng Z; Li T; Chu J; Hu W; Chen X; Han Q; Sun N; Liu X; Sun H; Shen Y
    J Affect Disord; 2024 Nov; 364():279-285. PubMed ID: 39137837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of polygenic risk for major psychiatric illness with subcortical volumes and white matter integrity in UK Biobank.
    Reus LM; Shen X; Gibson J; Wigmore E; Ligthart L; Adams MJ; Davies G; Cox SR; Hagenaars SP; Bastin ME; Deary IJ; Whalley HC; McIntosh AM
    Sci Rep; 2017 Feb; 7():42140. PubMed ID: 28186152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
    Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic scores for schizophrenia and major depression are associated with psychosocial risk factors in children: evidence of gene-environment correlation.
    Machlitt-Northen S; Keers R; Munroe PB; Howard DM; Trubetskoy V; Pluess M
    J Child Psychol Psychiatry; 2022 Oct; 63(10):1140-1152. PubMed ID: 35781881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
    Ikeda M; Takahashi A; Kamatani Y; Momozawa Y; Saito T; Kondo K; Shimasaki A; Kawase K; Sakusabe T; Iwayama Y; Toyota T; Wakuda T; Kikuchi M; Kanahara N; Yamamori H; Yasuda Y; Watanabe Y; Hoya S; Aleksic B; Kushima I; Arai H; Takaki M; Hattori K; Kunugi H; Okahisa Y; Ohnuma T; Ozaki N; Someya T; Hashimoto R; Yoshikawa T; Kubo M; Iwata N
    Schizophr Bull; 2019 Jun; 45(4):824-834. PubMed ID: 30285260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic risk for immuno-metabolic markers and specific depressive symptoms: A multi-sample network analysis study.
    Kappelmann N; Czamara D; Rost N; Moser S; Schmoll V; Trastulla L; Stochl J; Lucae S; ; Binder EB; Khandaker GM; Arloth J
    Brain Behav Immun; 2021 Jul; 95():256-268. PubMed ID: 33794315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk for depression, anxiety and neuroticism are associated with the severity and rate of change in depressive symptoms across adolescence.
    Kwong ASF; Morris TT; Pearson RM; Timpson NJ; Rice F; Stergiakouli E; Tilling K
    J Child Psychol Psychiatry; 2021 Dec; 62(12):1462-1474. PubMed ID: 33778956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited association between infections, autoimmune disease and genetic risk and immune activation in severe mental disorders.
    Werner MCF; Wirgenes KV; Shadrin AA; Lunding SH; Rødevand L; Hjell G; Ormerod MBEG; Haram M; Agartz I; Djurovic S; Melle I; Aukrust P; Ueland T; Andreassen OA; Steen NE
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110511. PubMed ID: 35063598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic associations of neurodevelopmental genes in suicide attempt.
    Sokolowski M; Wasserman J; Wasserman D
    Mol Psychiatry; 2016 Oct; 21(10):1381-90. PubMed ID: 26666204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.